Meet the regional finalists of I Love My Pharmacist: Northern England The public has until 21 July 2016 to vote for their favourite regional finalist of the 2016 I Love My Pharmacist Award. The pharmacist with the highest number of votes in each region will then meet with the judging panel who will decide the 2016 champion.…
NICE approves heart failure therapy Entresto A new combination treatment for heart failure has been recommended for NHS use by the National Institute for Health and Care Excellence.…
Evidence mounts on benefits of lowering threshold for use of antihypertensives All patients at high risk of heart disease including those with normal blood pressure should be considered eligible for blood pressure-lowering drugs, new research suggests.…
Review of 2015: ten developments that are changing pharmacy The pharmacy landscape continues to shift amid a backdrop of austere UK public spending and the rising spectre of centralised dispensing in the community. The Pharmaceutical Journal presents ten developments that affected pharmacists in 2015.…
New heart failure drug extends survival by up to two years A re-analysis of trial data reveals that the highly effective new drug sacubitril-valsartan could extend life by two years compared with enalapril for cardiovascular patients.…
Negative media coverage about statins may lead patients to stop therapy early Negative press coverage about statins has been linked to patients deciding to stop taking their statin therapy too early, researchers warn.…
Heart failure treatment Entresto recommended for approval in Europe Entresto, a combination of valsartan and sacubitril, could receive a marketing authorisation after a recommendation from the European Medicines Agency.…
Sacubitril/valsartan combination fast-tracked to heart failure patients A drug to reduce the risk of cardiovascular mortality and morbidity in adults with heart failure and reduced ejection fraction is being fast-tracked to patients under the UK’s Early Access to Medicines Scheme.…
Researchers boost hypertension treatment using unconventional approach Using approved drugs in unconventional ways could help improve compliance in patients with hypertension, according to a study in The Journal of Clinical Hypertension.…
FDA approves new heart failure combination therapy The US Food and Drug Administration has approved a new drug for heart failure that has “overwhelming benefit” for patients, according to the researchers who trialled the medicine.…
